ストックスクリーナーアプリを入手
4.43
1.77%
-0.08
前日終値:
$4.51
開ける：
$4.55
24時間の取引高:
51,888
Relative Volume:
0.66
時価総額：
$36.88M
収益：
$442.00K
当期純損益:
$-30.46M
株価収益率:
-0.9933
EPS:
-4.46
ネットキャッシュフロー:
$-27.47M
1週間 パフォーマンス:
-7.90%
1か月 パフォーマンス:
-7.71%
6か月 パフォーマンス:
-14.15%
1年 パフォーマンス:
-50.74%
1日の値動き範囲:
$4.40
$4.70
1週間の範囲:
$4.40
$4.99
52週間の値動き範囲:
$3.8181
$10.40
Clene Inc Stock (CLNN) Company Profile
名前
Clene Inc
電話
801-676-9695
住所
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
CLNN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
4.43 | 36.88M | 442.00K | -30.46M | -27.47M | -4.46 |
|
KHC
Kraft Heinz Co
|
31.13 | 37.80B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
61.00 | 33.63B | 19.90B | 2.60B | 2.80B | 4.60 |
|
K
Kellanova
|
82.66 | 28.11B | 12.80B | 1.01B | 927.00M | 2.91 |
|
MKC
Mccormick Co Inc
|
80.14 | 21.49B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.65 | 16.28B | 11.92B | 805.04M | 1.01B | 1.46 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-10-04 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-07-18 | 開始されました | H.C. Wainwright | Buy |
| 2022-05-02 | 開始されました | Canaccord Genuity | Buy |
| 2021-09-28 | 開始されました | Oppenheimer | Outperform |
Clene Inc (CLNN) 最新ニュース
Clene Inc. (NASDAQ:CLNN) Short Interest Up 10.3% in January - Defense World
Nanotechnology Stocks To ResearchFebruary 13th - MarketBeat
Could a New Drug Help Restore Vision? Early Findings in Myelin Repair - Securities.io
7 Best Nanotech Penny Stocks to Invest In - Insider Monkey
Is Clene Inc. (CLNN) the Best Nanotech Penny Stock to Invest In? - Insider Monkey
Nanotechnology Stocks To Watch TodayFebruary 09th - MarketBeat
Promising Nanotechnology Stocks To Follow TodayFebruary 11th - MarketBeat
Nanotechnology Stocks To Keep An Eye OnFebruary 08th - MarketBeat
Critical LDAP Vulnerability Puts Windows Systems at Risk - Experts' club
Best Nanotechnology Stocks To Watch NowFebruary 07th - MarketBeat
Promising Nanotechnology Stocks To Watch TodayFebruary 06th - MarketBeat
Nanotechnology Stocks To Follow NowFebruary 05th - MarketBeat
Promising Nanotechnology Stocks To Watch Today – February 06th - Armenian Reporter
Nanotechnology Stocks To Add to Your WatchlistFebruary 04th - MarketBeat
Clene Inc. secures additional NIH grant funds for ALS therapy - MSN
Promising Nanotechnology Stocks To Keep An Eye OnJanuary 31st - MarketBeat
Best Nanotechnology Stocks To Follow TodayJanuary 30th - MarketBeat
Clene Inc. secures additional NIH grant funds for ALS therapy By Investing.com - Investing.com UK
NATR Stock Surges Over 5% Amid Strong Financial Performance - GuruFocus.com
Clene files to sell 1.15M shares of common stock by selling shareholders - MSN
Clene (CLNN) Stock Price, News & Analysis - MarketBeat
3 US Growth Stocks With High Insider Ownership And Revenue Growth Up To 25% - Yahoo Finance
IBN Coverage: Clene (NASDAQ: CLNN) Paves Cash Runway to Advance CNM-Au8(R) for ALS - Nasdaq
Clene Secures $10 Million Debt Facility to Advance ALS Drug Development - Citybuzz
Clene (NASDAQ: CLNN) Paves Cash Runway To Advance CNM-Au8(R) For ALS - Barchart
3 US Growth Stocks With High Insider Ownership - Yahoo Finance
IBN Coverage: Clene (NASDAQ: CLNN) Receives FDA Roadmap on Potential Accelerated Pathway for CNM-Au8(R) - Yahoo Finance
Clene Receives FDA Guidance on Potential Accelerated Approval Pathway for ALS Drug CNM-Au8 - Citybuzz
Clene (NASDAQ: CLNN) Receives FDA Roadmap on Potential Accelerated Pathway for CNM-Au8(R) - The Globe and Mail
Clene Secures $10M Debt Facility to Enhance Position - TipRanks
Clene Secures $10 Million Debt Facility to Advance ALS and Neurodegenerative Disease Treatments - Citybuzz
IBN Coverage: Clene (NASDAQ: CLNN) Secures $10M Debt Facility to Advance Neurodegenerative Disease Treatments - Yahoo Finance
Clene Improves Cash Position and Runway by Securing New Debt Facility to Pay Off Existing Senior Loan - The Manila Times
Real-World Evidence Helps Open Accelerated Approval Pathway For Neurodegeneration Therapies - News & Insights
Clene Inc. Provides Update on Corporate Presentation and ALS Clinical Trials - Defense World
IBN Coverage: Clene (NASDAQ: CLNN) Advances CNM-Au8 in ALS With FDA Guidance on Accelerated Approval Pathway - Yahoo Finance
FDA outlines steps to consider accelerated approval of CNM-Au8 - ALS News Today
Clene Receives FDA Guidance on Accelerated Approval Path for ALS Treatment CNM-Au8 - Citybuzz
Clene Gains FDA Support for ALS Treatment Approval - TipRanks
FDA Provides Roadmap for Accelerated Approval Pathway Through Submission of Additional CNM-Au8® Biomarker Data in ALS - The Manila Times
FDA Opens Accelerated Approval Path for Clene's Breakthrough ALS Treatment After 78% Survival Benefit - StockTitan
Clene (NASDAQ:CLNN) Given New $84.00 Price Target at Benchmark - Defense World
Clene shares hold Buy rating as analyst sees FDA decision impacting time to market - Investing.com
Roth Capital Has Bearish Forecast for Clene FY2024 Earnings - Defense World
Clene (NASDAQ:CLNN) Price Target Lowered to $83.00 at Canaccord Genuity Group - Defense World
HC Wainwright Reaffirms Buy Rating for Clene (NASDAQ:CLNN) - Defense World
AWM Investment Company, Inc. Expands Stake in Clene Inc - GuruFocus.com
Clene price target lowered to $83 from $86 at Canaccord - Yahoo Finance
ARMISTICE CAPITAL, LLC Acquires New Stake in Clene Inc - GuruFocus.com
Certain Warrants of Clene Inc. are subject to a Lock-Up Agreement Ending on 15-NOV-2024. - Marketscreener.com
Clene Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Clene Inc (CLNN) 財務データ
収益
当期純利益
現金流量
EPS
Clene Inc (CLNN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Mortenson Mark | Chief Science Officer |
Sep 30 '24 |
Buy |
4.75 |
20,512 |
97,432 |
28,949 |
| Etherington Robert Dee | Chief Executive Officer |
Sep 30 '24 |
Buy |
4.75 |
10,000 |
47,500 |
40,149 |
| Etherington Robert Dee | Chief Executive Officer |
Jul 29 '24 |
Option Exercise |
3.00 |
27,320 |
81,960 |
30,149 |
| General Resonance LLC | 10% Owner |
Apr 30 '24 |
Sale |
0.42 |
13,000 |
5,416 |
15,326,712 |
| General Resonance LLC | 10% Owner |
May 01 '24 |
Sale |
0.40 |
13,000 |
5,148 |
15,313,712 |
| General Resonance LLC | 10% Owner |
Apr 24 '24 |
Sale |
0.33 |
10,000 |
3,278 |
15,349,712 |
| General Resonance LLC | 10% Owner |
Apr 09 '24 |
Sale |
0.39 |
22,500 |
8,674 |
15,428,212 |
1.60%
2.53%
大文字化:
|
ボリューム (24 時間):